CD8A and carcinoma: Despite the CD4 background, we could identify co-localization of this marker with CD3, and surprisingly we observed small quantities of double-positive CD4+ CD8+ expressing with CD3 in the carcinoma cases, although the secondary antibody was adjusted to eliminate possible nonspecific binding, an important aspect of any multi-antigen staining and a frequently neglected step23.